Compare ZVRA & WLKP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZVRA | WLKP |
|---|---|---|
| Founded | 2006 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 689.4M | 752.5M |
| IPO Year | 2015 | 2014 |
| Metric | ZVRA | WLKP |
|---|---|---|
| Price | $10.30 | $21.20 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $25.00 | N/A |
| AVG Volume (30 Days) | ★ 817.1K | 18.0K |
| Earning Date | 11-04-2026 | 10-29-2026 |
| Dividend Yield | N/A | ★ 8.87% |
| EPS Growth | ★ 159.21 | N/A |
| EPS | ★ 0.74 | N/A |
| Revenue | $106,470,000.00 | ★ $1,166,695,000.00 |
| Revenue This Year | $43.97 | $16.25 |
| Revenue Next Year | $15.93 | $5.23 |
| P/E Ratio | ★ $13.76 | $15.30 |
| Revenue Growth | ★ 350.91 | 2.71 |
| 52 Week Low | $8.01 | $17.75 |
| 52 Week High | $15.04 | $23.88 |
| Indicator | ZVRA | WLKP |
|---|---|---|
| Relative Strength Index (RSI) | 35.04 | 38.17 |
| Support Level | $10.18 | $20.97 |
| Resistance Level | $11.07 | $22.27 |
| Average True Range (ATR) | 0.38 | 0.28 |
| MACD | -0.11 | -0.01 |
| Stochastic Oscillator | 0.32 | 1.27 |
Zevra Therapeutics Inc is a commercial-stage company with a late-stage pipeline committed to bringing life-changing therapeutics to people living with rare diseases. The Company is focused on expanding patient access, progressing its pipeline toward key milestones, and delivering meaningful outcomes for patients with unmet needs. The commercialization of its product, marketed in the United States for Niemann-Pick disease type C (NPC), a rare, progressive neurodegenerative disease, provides a corporate foundation and demonstrates its ability to advance therapies from development to market.
Westlake Chemical Partners LP is a part of the chemical industry in the United States. Its operations are conducted through OpCo, it acquires and develops ethylene production facilities, which convert ethane into ethylene. OpCo sells ethylene and its co-products, such as propylene, crude butadiene, pyrolysis gasoline, and hydrogen, to Westlake and other customers located in the United States. Its assets include three ethylene production facilities in Calvert City, Kentucky, and Lake Charles, Louisiana.